The latest bull market has plenty of intriguing buying opportunities.
Growth stocks with wide moats and strong financials can compound investor returns with time.
These healthcare stocks have clear paths to growth over the next few years.
These top healthcare stocks are no-brainer buys in 2024 and beyond.
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.
/Biogen%20Inc%20logo%20on%20HQ-by%20Tada%20Images%20via%20Shutterstock.jpg)
Biogen underperforms the Nasdaq Composite, and analysts remain cautiously optimistic about the stock’s prospects.
It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes.
Lilly is a good pick...but this one is better.
Evergreen business models make it easier to hold for the long run.
Want peace of mind about your investments? Consider these great stocks.